Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-082027
Filing Date
2025-08-29
Accepted
2025-08-28 21:47:52
Documents
118
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0254438-20f_alterity.htm   iXBRL 20-F 2004808
2 CERTIFICATION ea025443801ex12-1_alterity.htm EX-12.1 10049
3 CERTIFICATION ea025443801ex12-2_alterity.htm EX-12.2 10110
4 CERTIFICATION ea025443801ex13-1_alterity.htm EX-13.1 4204
5 CERTIFICATION ea025443801ex13-2_alterity.htm EX-13.2 4115
6 CONSENT OF PRICEWATERHOUSECOOPERS ea025443801ex15-1_alterity.htm EX-15.1 1541
7 AUDITOR'S INDEPENDENCE DECLARATION ea025443801ex15-2_alterity.htm EX-15.2 658
8 GRAPHIC image_001.jpg GRAPHIC 99644
  Complete submission text file 0001213900-25-082027.txt   8947177

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE athe-20250630.xsd EX-101.SCH 108843
10 XBRL CALCULATION FILE athe-20250630_cal.xml EX-101.CAL 48900
11 XBRL DEFINITION FILE athe-20250630_def.xml EX-101.DEF 355566
12 XBRL LABEL FILE athe-20250630_lab.xml EX-101.LAB 675230
13 XBRL PRESENTATION FILE athe-20250630_pre.xml EX-101.PRE 381507
121 EXTRACTED XBRL INSTANCE DOCUMENT ea0254438-20f_alterity_htm.xml XML 1376965
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 251275682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)